Our customers' Feedback
Search:
Perform search
Categories list

Generic Namenda

News
Namenda
Namenda photo

Generic Namenda (Memantine)

Alzheimer's And Parkinson's

PackagePricePer PillSavingsOrder
5mg × 10 pills$11.95$1.19Add to cart
5mg × 20 pills$19.95$1.00$3.95Add to cart
5mg × 30 pills$24.95$0.83$10.90Add to cart
5mg × 60 pills$39.95$0.67$31.75Add to cart
5mg × 90 pills$54.95$0.61$52.60Add to cart

PackagePricePer PillSavingsOrder
10mg × 10 pills$14.95$1.49Add to cart
10mg × 20 pills$19.95$1.00$9.95Add to cart
10mg × 30 pills$26.95$0.90$17.90Add to cart
10mg × 60 pills$49.95$0.83$39.75Add to cart
10mg × 90 pills$69.95$0.78$64.60Add to cart

Most popular quantity.
Parlodel
$ 1.50
Generic Parlodel
(Bromocriptine 2.5mg)
Reminyl
$ 1.50
Generic Reminyl
(Galantamine 4/8mg)
Requip
$ 0.67
Generic Requip
(Ropinirole 0.25/0.5/1/2mg)
Sinemet
$ 0.57
Generic Sinemet
(Carbidopa - Levodopa 10mg + 100/25mg + 100/25mg + 250mg)
Sinemet Cr
$ 0.96
Generic Sinemet Cr
(Carbidopa - Levodopa 50mg + 200mg)
Stalevo
$ 0.72
Generic Stalevo
(Carbidopa Levodopa Entacapone 25mg + 100mg + 200mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Allergan plc Ordinary Shares Wins Expanded Label for Avycaz: a Significant Victory? - Bidness ETC

    Bidness ETCAllergan plc Ordinary Shares Wins Expanded Label for Avycaz: a Significant Victory?Bidness ETCAllergan's third top selling product, Namenda, an Alzheimer's curing drug, is also advancing declining sales on the back of rising generic competition.

  • Allergan's stellar Viberzi coverage bodes well for future launches: Analyst - FiercePharma

    FiercePharmaAllergan's stellar Viberzi coverage bodes well for future launches: AnalystFiercePharmaSome of Allergan's key products are coming up against serious competition--meaning it'll be up to the Dublin drugmaker's new launches to keep the engine going strong.

  • Actavis Says Namenda Product-Hopping Suit Has No Hop - Law360 (subscription)

    Actavis Says Namenda Product-Hopping Suit Has No HopLaw360 (subscription)Law360, New York (December 23, 2015, 8:14 PM ET) -- Pharmaceutical companies Actavis and Merz told a New York federal court Tuesday they cannot be sued for “product hopping” the Alzheimer's treatment Namenda, because the drug's original version .

  • Adamas Announces Additional ADS-5102 Data for the Treatment of Levodopa-induced Dyskinesia at the International ... - Nasdaq

    Market ExclusiveAdamas Announces Additional ADS-5102 Data for the Treatment of Levodopa-induced Dyskinesia at the International .

  • Allergan plc Ordinary Shares: Debt Will Not Impede Strong Growth - Bidness ETC

    Bidness ETCAllergan plc Ordinary Shares: Debt Will Not Impede Strong GrowthBidness ETCAllergan PLC (NYSE:AGN) is expected to complete the sale of its generic drug business to Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) by this month's end.

    Copyright © cheapgenerics24.com